-
1 Comment
CGN Nuclear Technology Development Co., Ltd is currently in a long term downtrend where the price is trading 0.6% below its 200 day moving average.
From a valuation standpoint, the stock is 66.4% cheaper than other stocks from the Industrials sector with a price to sales ratio of 1.7.
CGN Nuclear Technology Development Co., Ltd's total revenue rose by 0.4% to $2B since the same quarter in the previous year.
Its net income has increased by 92.7% to $55M since the same quarter in the previous year.
Finally, its free cash flow fell by 492.3% to $-198M since the same quarter in the previous year.
Based on the above factors, CGN Nuclear Technology Development Co., Ltd gets an overall score of 3/5.
CGN Nuclear Technology Development Co., Ltd. engages in the research and development, manufacture, and sale of electron accelerators in China. The company offers high-energy linear accelerator, earth nano accelerator, electronic curtain accelerator, dg resonant transformer type accelerator, industrial flaw detection accelerator, and electron beam. It also provides irradiation sterilization and polymer material irradiation modification services. In addition, the company offers cable polymer materials, such as PVC cable material, POE cable material, and PE sheath material; fiber optic cables using tight-buffered TPEE, TPV, and TPO; biodegradable film bag and straw modification materials; modified nylon (pa), including high CTI bromine-based flame retardant, red phosphorus flame retardant, nitrogen flame retardant, high temperature resistant, toughened PA, and reinforced PA; and flame-retardant modified polycarbonate (PC), reinforced PC, PG/PBT alloy, PC/ABS alloy, light-diffusing PC. Further, it provides modified polyester; fiberglass reinforced modified polypropylene (PP), mineral-filled PP, toughened PP, high-gloss PP, flame-retardant PP, and weather-resistant PP; HDPE prepreg tape material, PP prepreg tape material, and PA prepreg tape material; high melt flow index meltblown PP and radiation-resistant sterilization meltblown PP; and radiation-resistant polypropylene products. Additionally, the company offers healthcare products comprising proton therapy tumor system equipment and radioactive medical isotopes; and measurement and control equipment, including silicon photomultiplier. The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was incorporated in 1993 and is based in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000881.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026